Compugen Licenses Gencarta to Avalon in Drug Target Collaboration | GenomeWeb

NEW YORK, April 3 – Compugen has licensed its new Gencarta database of annotated genomic, transcription, and proteomic data to Avalon Pharmaceuticals of Gaithersburg, MD, and has agreed to collaborate with Avalon on drug and diagnostic target identification research, the companies said Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."